Application 203335
- Type
- ANDA
- Sponsor
- MAYNE PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | CAPSULE;ORAL | 325MG;50MG;40MG;30MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68308-312 | Butalbital, Aspirin, Caffeine, and Codeine Phosphate | Butalbital, Aspirin, Caffeine, and Codeine Phosphate | Mayne Pharma Inc. | ANDA | Current |
| 68308-312 | Butalbital, Aspirin, Caffeine, and Codeine Phosphate | Butalbital, Aspirin, Caffeine, and Codeine Phosphate | Mayne Pharma Inc. | ANDA | Current |